Zacks.com on MSN24d
KOD Completes Enrollment in Phase III Study for Eye Disease CandidateFollowing a successful phase I study, Kodiak has advanced KSI-501 into phase III through the DAYBREAK study, which will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback